FAST and PSFS: Assessment and Validation of Two Functional Scales in Patients With Knee OA in Singapore

June 23, 2025 updated by: SingHealth Polyclinics

Functional Activity Scoring Tool (FAST) and Patient-Specific Functional Scale (PSFS): Assessment and Validation of Two Functional Scales in Patients With Knee Osteoarthritis (OA) in Singapore

The new National One-Rehab framework mandates the use of the Patient-Specific Functional Scale (PSFS) as an outcome measure to track patients' rehabilitation progress. Anecdotally, we have encountered patients (especially elderly ≥ 65 years old) with difficulty understanding and completing such questionnaire accurately. We developed a pictorial functional scale (Functional Activity Scoring Tool, FAST) with reference to the successful application of the Wong-Baker FACES pain rating scale. Concurrently, we hope to validate PSFS and FAST against Knee injury and Osteoarthritis Outcome Score (KOOS) which is validated in Singapore population.

This study aims to investigate the reliability and validity of the PSFS and FAST in patients with knee osteoarthritis. We hypothesize that both the PSFS and FAST can be used to measure difficulty in performing activities of daily living in patients with knee osteoarthritis in a reliable and valid manner.

The FAST and PSFS questionnaires will be administered to patients in SingHealth Polyclinics with knee osteoarthritis to explore the psychometric and clinimetric properties. Eligibility criteria were: age 45 and above, proficient in English, diagnosed with knee osteoarthritis. Patients were excluded if they have underlying medical or trauma conditions (i.e., trauma, fracture, infection, inflammatory disease, tumor), history of knee surgery within the last 3 months, or clinically recognizable cognitive impairment.

Eligible patients will be informed about the purpose of the study and the confidentiality and anonymity of the process. After giving written consent they will complete a questionnaire on demographic and clinical characteristics and the sets of outcome measures (FAST, KOOS, PSFS). Participants will then return at two-to-three weeks later to complete the sets of outcome measures again and GROC, and to state their preferred outcome measures. Statistical analysis will be conducted to evaluate the validity and reliability of PSFS and FAST against KOOS.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Validation

The FAST and PSFS questionnaires will be administered to patients in SingHealth Polyclinics (SHP) with knee osteoarthritis to explore the psychometric and clinimetric properties. Eligibility criteria were: age 45 and above, proficient in English, diagnosed with knee osteoarthritis. Patients were excluded if they have underlying medical or trauma conditions (i.e., trauma, fracture, infection, inflammatory disease, tumor), history of knee surgery within the last 3 months, or clinically recognizable cognitive impairment. Statistical analysis will be conducted to evaluate the validity and reliability of PSFS and FAST against KOOS.

Questionnaire

  1. FAST

    FAST is developed by Mr. Tang Zhi Yin and Mr. Ng Khim Siong from SHP physiotherapy department. It is a pictorial scale with 7 emotion faces (different degrees of sadness to happiness) on stairs to depict corresponding level of difficulty a patient is experiencing during performing activity. Short descriptions are labelled under the faces, as well as a scale of 0-10 to guide the patient to rate his/her functional difficulty. The patient is asked to identify up to 3 activities that being affected due to his/her current musculoskeletal pain, and to rate each activity on the FAST.

  2. PSFS

    The PSFS is a self-reported, patient-specific measure that assesses patients' functional status. Patients are asked to identify three activities that are most affected by their condition and then rate their ability on a 0-10 scale, where 0 is unable to perform activity and 10 is able to perform activity at the same level as before the onset of symptoms.

  3. KOOS

    The KOOS is a knee-specific instrument, developed to assess the patients' opinion about their knee and associated problems. It is a validated tool in Singapore for knee osteoarthritis patients. It has a total of 42 items in 5 subscales i.e., pain, other symptoms, function in daily living, function in sport and recreation, and knee-related quality of life. Scores are interpreted independently for each subscale. As our study focuses on function, we only apply subscales for function in daily living, function in sport and recreation, and knee-related quality of life.

  4. GROC

The GROC is an outcome measure that assesses patients' self-perception of change in their condition between sessions. Participants were asked to rate the change in their condition on a 15-point transitional scale from -7 (a very great deal worse) to 7 (a very great deal better). The GROC scale is easy to administer, requires minimal skills or training, has good reproducibility, and is sensitive to change.

Data collection

Eligible patients will be informed for the purpose of the study and the confidentiality and anonymity of the process. After giving written consent they will complete a questionnaire on demographic and clinical characteristics and the sets of outcome measures (FAST, KOOS, PSFS). Participants will then return at two-to-three weeks later to complete the sets of outcome measures again and GROC, and to state their preferred outcome measures.

Statistical analysis

All statistical analysis will be conducted using SPSS 26 for Windows. To investigate validity, the discriminant validity was evaluated by the Spearman correlation coefficient according to the following criteria: high (rho ≥ 0.60); moderate (rho < 0.60 - ≥ 0.30); or low (rho <0.30). To analyze the test-retest reliability, the intraclass correlation coefficient (ICC) is calculated. An ICC value of less than 0.40 indicated poor reliability, whereas values between 0.40 and 0.75 indicated fair to good reliability; an ICC value of greater than 0.75 showed excellent reliability.

Study Type

Observational

Enrollment (Actual)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Singapore, Singapore
        • SingHealth Polyclinics

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients with knee osteoarthritis

Description

Inclusion criteria:

  • individuals above the age of 45
  • proficient in colloquial/conversational English
  • diagnosed with knee osteoarthritis.

Exclusion criteria:

  • additional underlying medical or trauma conditions of the knees (e.g., trauma, fracture, infection, inflammatory disease, tumour)
  • history of knee surgery within the last three months
  • clinically recognizable cognitive impairment that inhibits the completion of the questionnaires.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients with knee osteoarthritis
Individuals who are medically diagnosed with knee osteoarthritis and eligible for physiotherapy care in SingHealth Polyclinics will be recruited. Inclusion criteria include: individuals above the age of 45, proficient in colloquial/conversational English, and diagnosed with knee osteoarthritis. Exclusion criteria include additional underlying medical or trauma conditions of the knees (e.g., trauma, fracture, infection, inflammatory disease, tumour), history of knee surgery within the last three months, or clinically recognizable cognitive impairment that inhibits the completion of the questionnaires.
routine referral-based physiotherapy treatment for patients with knee osteoarthritis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in functional status as assessed by Functional Activity Scoring Tool (FAST)
Time Frame: 3 weeks from baseline examination
Change in functional status as assessed by FAST using a points system
3 weeks from baseline examination
Change in functional status as assessed by Patient-Specific Functional Scale (PSFS)
Time Frame: 3 weeks from baseline examination
Change in functional status as assessed by PSFS using a points system
3 weeks from baseline examination
Change in functional status as assessed by Knee injury and Osteoarthritis Outcome Score (KOOS)
Time Frame: 3 weeks from baseline examination
Change in functional status as assessed by KOOS using a points system
3 weeks from baseline examination
Patients' self-perception of change in their knee condition as assessed by Global Rating of Change Score (GROC)
Time Frame: 3 weeks from baseline examination
Patients' self-perception of change in their knee condition as assessed by GROC using a points system
3 weeks from baseline examination

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Zhi Yin Tang, SingHealth Polyclinics

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 13, 2023

Primary Completion (Actual)

September 15, 2023

Study Completion (Actual)

September 15, 2023

Study Registration Dates

First Submitted

October 18, 2022

First Submitted That Met QC Criteria

October 20, 2022

First Posted (Actual)

October 21, 2022

Study Record Updates

Last Update Posted (Actual)

June 26, 2025

Last Update Submitted That Met QC Criteria

June 23, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified individual participant data (IPD) that will be shared include:

  • Demographics data
  • Outcome data for primary and secondary endpoints

IPD Sharing Time Frame

IPD will be available beginning 6 months after publication of the primary results and will remain available for 5 years thereafter.

IPD Sharing Access Criteria

Data will be made available to qualified researchers upon reasonable request, subject to approval by the sponsor and completion of a data use agreement.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on Physiotherapy

Subscribe